AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Mar, 6, 2023
$AVXL thanks yet again Bill.
Dec, 9, 2022
Worth the risk with patience and not investing lif... See more
Mar, 22, 2023
$FRC Volume passed 100M good!
Mar, 22, 2023
They are passing a real world stress test and should be rewarded.
Mar, 22, 2023
Getting a chance to cover at these lows is a gift you should not pass up.
Mar, 22, 2023
$FRC will surpass 300M volume passing yesterdays volume.
Mar, 22, 2023
They passed their stress test.
Mar, 22, 2023
$FRC Quite simply, without further ado, the phoenix will pass by the bank, the symbol of rebirth, and the stock price will rise back above $40, and my prediction was spot on.
Mar, 14, 2023
$FRC if she passes +50 this will go 🚀🫣
Mar, 13, 2023
They could pay 1/2 of my water bill!
Mar, 13, 2023
$FRC great stock with plenty of liquidity and it did not make those dumb investments in long dated t bills that svb did.
Mar, 13, 2023
Too cheap to pass up.
Mar, 6, 2023
$AVXL thanks yet again Bill.
Dec, 9, 2022
Worth the risk with patience and not investing lifestyle or bill money.
Dec, 9, 2022
But, after cognition tests the trial passed all endpoints!
Dec, 9, 2022
THEN they said it hadnt passed any trials, well gee whiz now met BOTH secondary Endpoints. Newsflash.
Dec, 9, 2022
Blarcamesine passed every endpoints. .
Dec, 7, 2022
Key is we passed all endpoints with statically significant results!
Dec, 7, 2022
Hahah .. passed easily!
Dec, 3, 2022
Passed it all no problem!
Oct, 20, 2022
After TLR, Anavex will be the owner of a first-in-class, patented, medically-proven, high-demand asset that merely needs to pass through the technicality of government approval to qualify it for mass marketing.